Aseptic Fill Finish and Lyophilization Services

Aseptic Fill Finish and Lyophilization Services
Product Description

LSNE has a long track record of success in pre-clinical, clinical and commercial aseptic fill finish, with hundreds of aseptic batches produced over two decades.  With seven aseptic automated fill lines to meet your capacity demands, we have the flexibility to sterile fill a range of dosage forms with batch sizes from a few hundred up to 200,000 units. 

Vial Filling

  • 2 mL - 100 mL vials
  • 0.5 mL - 100 mL fill volume
Syringe Filling
  • 1 mL, 1mL long, 2.25 mL and 3 mL PFS
  • 0.1 mL - 3 mL fill volume
Dropper Bottle Filling
  • For ophthalmics-only
  • 5 mL and 10 mL bottles
  • 0.5 mL - 10 mL fill volume

LSNE Contract Manufacturing

  • US
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
Contract Service
Manufacturer/Innovator
Specifications
  • Selling Points
    International Approvals/Standards; Quality Service

LSNE Contract Manufacturing

  • US
  • 2015
    On CPHI since
  • 250 - 499
    Employees
Company types
Contract Service
Manufacturer/Innovator

More Products from LSNE Contract Manufacturing (2)

  • Formulation and Lyophilization Cycle Development

    Product Formulation and Lyophilization Cycle Development

    LSNE is uniquely equipped to develop your formulation or lyophilization cycle from scratch or optimize your existing cycle to provide you with a commercially desirable process. LSNE utilizes Quality-by-Design (QbD) to perform multiple experiments in parallel, or accelerate one project in your program by ...
  • Medical Device Manufacturing

    Product Medical Device Manufacturing

    By partnering with more than fifty medical device clients, LSNE has developed the knowledge and the capacity to offer a flexible approach to medical device manufacturing.  With two licensed cGMP facilities that support medical device manufacturing, we’re built from the ground up to provide low cos...

LSNE Contract Manufacturing resources (2)

  • News LSNE Receives Approval from AEMPS to Manufacture Biotechnology-based Therapeutic Products

    LSNE expands capabilities for aseptic fill finish of high-value biologics in Europe. This important approval builds upon LSNE’s well-established capabilities in providing aseptic fill finish of biologic products for clients at its US facilities.  These products include monoclonal antibodies, fusion proteins, replacement enzymes, plasmids, capsids, and oligonucleotides.
  • Video LSNE Corporate Overview - Delivering On Our Promises

    The Recognized Leader in Lyophilization and Sterile Manufacturing
    A history of execution. A reputation for excellence.

    Take an inside look at what LSNE has to offer as a leading contract development and manufacturing organization. Our people can help get your drug product or medical device into the hands of patients in need.